Vice President, Clinical Development-Neuroscience

About this role

Company:

At Annexon Biosciences we are a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases of the body, brain, and eye. Our novel scientific approach targets upstream C1q to block the classical complement inflammatory cascade before it starts, and its therapeutic candidates are designed to provide meaningful benefits across multiple autoimmune, neurodegenerative and ophthalmic diseases. With proof-of concept data in Guillain-Barré syndrome, Huntington’s disease and geographic atrophy, we are rigorously advancing our mid-to late-stage clinical trials to bring new potential treatments to patients as quickly as possible. At Annexon, you’ll be part of a team committed to making an impact together.

For more information on Annexon and our pipeline, check out our site Annexon Biosciences & Annexon Pipeline . We trade on Nasdaq under the ticker symbol ANNX and are headquartered in Brisbane, CA.

We're seeking exceptional talent from all backgrounds to fuel our growth. At Annexon, we're building a diverse, equitable, and inclusive workplace. We value unique perspectives and unconventional paths. If you're the best candidate for the job, even if you don't perfectly fit the traditional mold, we encourage you to apply. Learn more about our commitment to diversity, equity, inclusion, and our company culture !

Position:

We are seeking an accomplished and visionary leader to join our team as Vice President, Clinical Development-Neuroscience. The Vice President, Clinical Development-Neuroscience will serve as a key leader in driving the clinical strategy and execution of the portfolio of programs in neurodegeneration and neuro-immunologic diseases. This role will be responsible for the strategy for the investigation of clinical candidates in this therapeutic area and support the end-to-end design and execution of clinical programs, from Phase I through Phase III, ensuring scientific integrity, regulatory compliance, and alignment with corporate objectives. The successful candidate will collaborate with cross-functional teams, lead clinical aspects of regulatory submissions, and establish critical partnerships with key opinion leaders and external stakeholders to advance clinical initiatives. The ideal candidate will bring strategic vision, proven expertise and success in pharmaceutical development for drug candidates for neurologic diseases, clinical trial design and execution, and the ability to manage complex programs in a fast-paced environment. This individual will play a crucial role in translating innovative therapeutic concepts into real-world treatments, including collaborating with discovery research, translational medicine, regulatory affairs, pharmacovigilance, biometrics, clinical pharmacology, medical affairs and clinical operations, shaping the company’s success in the rapidly evolving field of neurology.

Responsibilities include:

• Lead the strategic direction and execution of the portfolio of neuroscience clinical development programs, from early-phase through late-stage ensuring they are scientifically robust and meet regulatory requirements

• Collaborate cross-functionally with teams in discovery research, translational medicine, regulatory affairs, pharmacovigilance, biometrics, clinical pharmacology, medical affairs and clinical operations to ensure the successful execution of clinical development plans

• Drive the preparation, submission, and management of regulatory filings, including clinical trial applications, investigator brochures, study protocols, and marketing authorization dossiers (e.g., BLA/NDA, MAA) ensuring alignment with global regulatory guidelines (e.g., FDA, EMA).

• Analyze, interpret, and communicate data to inform key decisions, providing clear recommendations to guide clinical development strategy.

• Establish and maintain strategic relationships with key opinion leaders (KOLs), clinical investigators, and external stakeholders to advance clinical initiatives.

• Manage clinical trial budgets, timelines, and resources, ensuring the delivery of high-quality results aligned with corporate objectives.

• Regularly present clinical progress, data outcomes, and strategic recommendations to executive leadership, stakeholders, and external partners.

• Stay at the forefront of industry trends, scientific advancements, and regulatory developments to ensure the company remains competitive in the clinical development strategies.

• Identify potential risks in clinical development timelines, budgets, or regulatory pathways, and develop contingency plans to mitigate them.

Education, Experience, and Skills:

Required:

• MD or MD/PhD in with board certification in Neurology, Neuroscience, or a related field.

• 15-20 years of experience in clinical development, with a focus on CNS-related indications.

• Proven leadership in designing, managing, and executing clinical trials from early phase through late-stage development.

• Demonstrated experience in leading clinical development teams at a senior or executive level, ideally within a high-growth biotech or pharmaceutical environment.

• In-depth knowledge of global regulatory requirements and guidelines (e.g., FDA, EMA) and clinical development processes, including Experience in HA meetings, writing briefing books, attending/supporting meetings.

• Exceptional leadership, strategic thinking, and communication skills with a proven ability to influence across functions and levels.

• Ability to work effectively in a fast-paced, dynamic environment and manage multiple priorities.

• Strong analytical and problem-solving skills, with a data driven approach to decision making.

• Demonstrated success in building collaborations with cross-functional teams and external partners in a dynamic, fast paced environment.

Preferred:

• Experience with regulatory submissions and clinical trial oversigh

Similar jobs

• Vice President, Medical Affairs-Neuroscience — Annexonbioscience · San Francisco Bay Area
• Senior Vice President, Clinical Development — Amylyx · Cambridge, MA
• Vice President, Clinical Development (Oncology & Molecular Diagnostics) — Natera · Remote
• Vice President, Clinical Operations — Lexeotx · New York, New York
• Vice President, Head of Clinical Operations — Recursionpharmaceuticals · Remote
• Senior Director, Clinical Development — Loyal36 · Remote
• Senior Director, Clinical Development — Bridgebio · San Francisco - 1800 Owens
• Senior Director, Clinical Development — Annexonbioscience · San Francisco Bay Area